Internal Server Error

Sanguine - About the company

Sanguine is a series B company based in Los Angeles (United States), founded in 2010 by Brian Neman. It operates as a Building a databank of patient-derived data for advanced research. Sanguine has raised $5.53M in funding from Broadoak Capital Partners. The company has 379 active competitors, including 57 funded and 45 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.

Company Details

Building a databank of patient-derived data for advanced research. The company engages patients in biomedical research by delivering transparency throughout the research process. Sanguine collects and de-identifies patient-derived data in the form of biospecimen, and physician and self-reported information. These data are generated and then made available to researchers involved in drug and biomarker research and discovery with leading academic laboratories and companies, such as Vertex.
Social
XFacebook
Email ID
*****@sanguinebio.com
Registered Address
Sherman Oaks, California
Key Metrics
Founded Year
2010
Location
Los Angeles, United States
Stage
Series B
Total Funding
$5.53M in 6 rounds
Ranked
Employee Count
101 as on Sep 30, 2026
Similar Companies
Sign up to download Sanguine's company profile

Sanguine's funding and investors

Sanguine has raised a total funding of $5.53M over 6 rounds. Its first funding round was on Feb 22, 2013. Its latest funding round was a Conventional Debt round on Oct 31, 2023 for $*****. 1 investor participated in its latest round. Sanguine has 11 institutional investors.

Here is the list of recent funding rounds of Sanguine:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 31, 2023
8065803
Conventional Debt
7327837
7382375
2105262
5263314
Jan 09, 2023
6451243
Series B
4507504
3356497
6130228
4123749
Feb 01, 2019
4825729
Grant (prize money)
2270986
6000744
2719529
lockAccess funding benchmarks and valuations. Sign up today!

Sanguine's founders and board of directors

Founder? Claim Profile
The founders of Sanguine is Brian Neman.
Here are the details of Sanguine's key team members:

Sanguine's Board of Directors

Sanguine's board has 4 active members. Brian Neman, Randy Socol, Tim Triche and Rudiger Hausherr are independent board members.
Here is the list of Sanguine's board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
11y 11m
opxtsuk
Independent board member
-
Current
4y 4m
ufbsnqs
Independent board member
-
Current
1y 7m
{kcrfev
Independent board member
-
Current
4y 5m

Sanguine's employee count trend

Sanguine has 101 employees as of Sep 26. Here is Sanguine's employee count trend over the years:
Employee count trend for Sanguine
lockUncover Sanguine's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Sanguine's Competitors and alternates

Top competitors of Sanguine include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of Sanguine, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Medidata
Medidata
1999, New York City (United States), Acquired
AI-based clinical trial management software for researchers
$41.5M
82/100
2nd
Logo for IQVIA
IQVIA
1982, Durham (United States), Public
Provider of clinical research and commercialization solutions for healthcare
$1.74M
80/100
3rd
Logo for Verily
Verily
2015, Dallas (United States), Series D
A data platform and technology company purpose-built to power AI-enabled precision health
$2.8B
78/100
4th
Logo for Tempus
Tempus
2015, Chicago (United States), Public
Developer of genomic testing and artificial intelligence tools for medicine
$1.05B
78/100
5th
Logo for Signant Health
Signant Health
2000, Plymouth Meeting (United States), Acquired
Provider of a software solution for clinical trial management
$3.4M
68/100
6th
Logo for Science 37
Science 37
2014, Los Angeles (United States), Acquired
Provider of a suite solution for clinical trials for researchers
$106M
67/100
7th
Logo for Massive Bio
Massive Bio
2014, New York City (United States), Series B
Provider of AI-based clinical trial management tool
$15.6M
64/100
8th
Logo for Wcg Clinical
Wcg Clinical
2012, Princeton (United States), Acquired
CRO offering regulatory and ethical review services for clinical research
-
64/100
9th
Logo for ESO
ESO
2004, Austin (United States), Series B
Provider of integrated software for emergency medical services
$50.4M
63/100
10th
Logo for TriNetX
TriNetX
2013, Cambridge (United States), Acquired
Provider of clinical trial management software for researchers and professionals
$102M
62/100
26th
Logo for Sanguine
Sanguine
2010, Los Angeles (United States), Series B
Building a databank of patient-derived data for advanced research
$5.53M
51/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Sanguine's competitors? Click here to see the top ones

Sanguine's Investments and acquisitions

Sanguine has made no investments or acquisitions yet.

Reports related to Sanguine

Here is the latest report on Sanguine's sector:

News related to Sanguine

lockFilter this list
Media has covered Sanguine for 1 event in last 1 year, It was about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Sanguine

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford